Antitopoisomerase drug action and resistance von Nitiss, J.L., Beck, W.T.

Volltext

Cytotoxicity of quinolones toward eukaryotic cells. Identification of topoisomerase. II. As the primary cellular target for the quinolone CP-115,953 in yeast von Elsea, S.H. (Vanderbilt University School of Medicine, Nashville, TN), Osheroff, N, Nitiss, J.L

Volltext

The top2-5 mutant of yeast topoisomerase II encodes an enzyme resistant to etoposide and amsacrine von Jannatipour, M., Liu, Y.X., Nitiss, J.L.

Volltext

Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks von Sabourin, M, Nitiss, J.L, Nitiss, K.C, Tatebayashi, K, Ikeda, H, Osheroff, N

Volltext

Molecular analysis of yeast and human type II topoisomerases. Enzyme-DNA and drug interactions von Strumberg, D, Nitiss, J.L, Dong, J, Kohn, K.W, Pommier, Y

Volltext

Metabolites of Daidzein and Genistein and Their Biological Activities von Chang, Yu-Chen, Nair, Muraleedharan G, Nitiss, John L

Volltext

Mutation of a Conserved Serine Residue in a Quinolone-resistant Type II Topoisomerase Alters the Enzyme-DNA and Drug Interactions von Strumberg, Dirk, Nitiss, John L., Rose, Angela, Nicklaus, Marc C., Pommier, Yves

Volltext

Four out of six human NYH small cell lung cancer cell lines resistant to ICRF-187 have either R162Q or Y165S functional mutations in the Walker ATP binding site of topoisomerase II... von Wessel, I, Jensen, L.H, Nitiss, J.L, Jensen, P.B, Sehested, M

Volltext

A mutation in yeast TOP2 homologous to a Quinolone-resistant mutation in bacteria: mutation of the amino acid homologous to Ser83 of Escherichia coli gyrA alters sensitivity to euk... von Hsiung, Y. (Children's Hospital Los Angeles, Los Angeles, CA.), Elsea, S.H, Osheroff, N, Nitiss, J.L

Volltext